|Slideshows|October 2, 2019

5 criteria for diagnosing ADHD

Author(s)Pat F. Bass III, MD, MS, MPH, David O Childers Jr., MD

When determining whether a diagnosis of attention-deficit/hyperactivity disorder (ADHD) is the correct diagnosis, here are 5 important criteria to consider.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

CBT and fluoxetine show comparable improvement for pediatric anxiety

ByBradley Peterson, MD

August 26th 2026

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

ByMorgan Ebert, Executive Editor

August 26th 2026

FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older

ByMorgan Ebert, Executive Editor

August 26th 2026

FDA authorizes first dual glucose-ketone monitor for children as young as 2

ByMorgan Ebert, Executive Editor

August 25th 2026

FDA approves nipocalimab as first treatment for warm autoimmune hemolytic anemia

ByMorgan Ebert, Executive Editor

August 25th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

5 criteria for diagnosing ADHD

Related Content

CBT and fluoxetine show comparable improvement for pediatric anxiety

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older

FDA authorizes first dual glucose-ketone monitor for children as young as 2

FDA approves nipocalimab as first treatment for warm autoimmune hemolytic anemia

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Mental health treatment increases among US children and teens

FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older

FDA authorizes first dual glucose-ketone monitor for children as young as 2

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

Parent smartphone use linked to slower vocabulary growth in young children